Logo

Course

Best of ACTHIV® 2025: Breaking the Weight Barrier: Comprehensive Obesity Treatment Approaches for People with HIV

Details

Published Date: 09/15/2025

Expiration Date: 09/15/2026

CE Credit: CME:0.75CNE: 0.75(Rx: 0.7)

Description

Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2025 conference for the frontline HIV care team, this activity will explore weight gain in people with HIV and potential management strategies.

Presenter(s)

Suman Srinivasa,MD, MS

Suman Srinivasa, MD, MS, is Assistant Professor of Medicine at Harvard Medical School, clinician in the Neuroendocrine and Pituitary Tumor Clinical Center, and investigator in the Metabolism Unit, Division of Endocrinology at the Massachusetts General Hospital. She also serves as Assistant Director within the Master of Medical Sciences in Clinical Investigation program at Harvard Medical School and serves as Co-Director of the MIRACLEs HIV program (Metabolic Investigations Researching Adipose and CardiovascuLar hEalth in HIV). Her clinical research trajectory has concentrated on exploring hormone-mediated mechanisms and treatment strategies for inflammation and cardiometabolic disease in HIV. In her clinical practice, she actively manages metabolic disease, lipodystrophy, and weight gain among persons with HIV and was an invited expert to the NIH workshop on obesity and fat metabolism among persons with HIV. Awards in recognition of her work include the NIH R01, NIH K23, Harvard Catalyst Medical Research Investigator Training Award, and Gilead Research Scholars in HIV. She is recipient of The Endocrine Society Early Investigator Award, the CROI Young Investigator Scholarship, and the Women in Endocrinology Young Investigator Award.

Learning Objectives

  • Recognize contributors of weight gain in HIV
  • Evaluate weight management strategies
  • Summarize recent studies of GLP-1RA use among persons with HIV (PWH)
  • Describe potential clinical challenges with GLP-1RA use
  • Assess the broad potential therapeutic benefit of GLP-1RAs

Continuing Education Credit Information